Remove Networking Remove Pharmaceutical Remove Pharmaceutical research Remove Safety
article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. More convenience and safety? Primarily because of a fact that the pharmaceutical industry has known for some time—constant, honest, and meaningful communication with prescribers is lacking in the post-pandemic world.

Pharma 52
article thumbnail

The Dark Side of the Pharmaceutical Industry: Are Treatments Being Blocked for Profit?

Pharma Marketing Network

The pharmaceutical industry is a major contributor to the global economy, generating billions of dollars in revenue every year by developing and selling life-saving drugs. In particular, there are concerns that the pharmaceutical industry may be blocking treatments in order to increase profits, potentially putting millions of lives at risk.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

7 It is currently being evaluated in a Phase Ib/IIa clinical study, demonstrating to date a good safety profile. While favourable safety has been reported up to the Phase II, the relevance of targeting the C-terminal portion of Abeta still needs to be confirmed.

article thumbnail

Dawn of a new indication: how to study drugs for aging 

Pharmaceutical Technology

Whether one refers to such research as “longevity”, “anti-aging” or “extending healthspan”, it is clear this area has evolved massively over the last few years with more scientists now eager to get drugs in this area from bench to bedside. Please check your email to download the Report.

FDA 145